vial
10mg (10mL)
PT-141
PT-141 (bremelanotide) is a melanocortin-receptor agonist researched for its centrally-mediated role in sexual desire and arousal, distinct from vascular-acting approaches. Under physician supervision, it is explored to support libido and sexual wellness where clinically appropriate.
Mechanism of action
How researchers describe PT-141 working at the receptor, signaling, neural, and regulatory levels. Mechanistic and investigational — shared to inform, never to promise an outcome.
Receptor Activation
PT-141 is a synthetic analog of alpha-melanocyte-stimulating hormone (alpha-MSH) and is associated with agonist activity at melanocortin receptors, with research emphasis on the MC4 receptor and secondary engagement of MC1R and MC3R. In study models, this binding is thought to act on central receptor populations rather than on peripheral vascular tissue, distinguishing it from PDE5-type mechanisms. Receptor affinity and selectivity remain an active area of pharmacological characterization.
Cell Signaling
Melanocortin receptors are Gs-protein-coupled, and research suggests that PT-141 engagement is associated with activation of adenylyl cyclase and downstream elevation of intracellular cyclic AMP (cAMP). This cAMP signaling, in turn, is linked in study models to protein kinase A activity and modulation of neuronal excitability. The net intracellular cascade is described in the literature as the proximal step translating receptor binding into altered neural output.
Neural Activity
PT-141 is primarily characterized as a centrally acting compound, and research explores its activity within hypothalamic circuitry, including regions such as the medial preoptic area that are associated with sexual motivation and arousal pathways. In study models, melanocortin signaling in these areas is linked to the modulation of dopaminergic and oxytocinergic tone relevant to desire. Its proposed effects are therefore framed around CNS signaling rather than direct peripheral hemodynamics.
Regulatory Pathways
Beyond reproductive pathways, melanocortin signaling is associated in research with broader autonomic and homeostatic regulation, including reported effects on appetite, energy balance, and inflammatory tone via MC3R/MC4R. Transient cardiovascular and blood-pressure responses have been described in study contexts, which is one reason physician oversight and as-needed dosing are emphasized. These systemic associations remain under investigation and are not established therapeutic endpoints.
Built around you, never one-size-fits-all
Who it's for
A physician may consider PT-141 for adults exploring physician-supervised support for libido and sexual wellness who prefer a centrally-mediated approach and are appropriate candidates after clinical evaluation.
What's included
Includes a 10 mg (10 mL) PT-141 vial preparation, a licensed-physician evaluation, and personalized as-needed dosing and administration guidance.
More information
A valid health screening is required before any order is fulfilled. After checkout you will receive instructions to complete the required intake. Orders are processed only once a licensed physician has reviewed and approved your screening. Each completed screening remains valid for 12 months.
- Personalized guidance, one-on-one with your care team.
- Full refund if a licensed physician determines the treatment isn't a fit.
Purity you can verify
Most peptides sold online are imported, unverified, and labeled to dodge the rules. We built the opposite — American-made, properly tested, and physician- supervised on every order.
- Manufactured in U.S. cGMP-registered facilities
- Every batch third-party tested with a Certificate of Analysis
- Reviewed and prescribed by U.S.-licensed physicians
- Cold-chain handling and discreet, tracked delivery
Related therapies
Begin PT-141 with a physician evaluation
One honest price, evaluation included. A licensed physician reviews your case before anything ships — with a full refund if it isn't the right fit.